Project Details
Projekt Print View

Unravelling fungal biosynthetic potential by heterologous expression of silent gene clusters in Aspergillus nidulans and LC-MS-based metabolomic analysis

Subject Area Pharmacy
Term from 2019 to 2023
Project identifier Deutsche Forschungsgemeinschaft (DFG) - Project number 410588509
 
Final Report Year 2023

Final Report Abstract

In this project we combined the power of genomics and synthetic biology with an integrated metabolomic profiling tool box to express silent/cryptic genes and to elucidate secondary metabolite (SM) pathways. Putative biosynthetic gene clusters (BGCs) from Penicillium crustosum, Pestalotiopsis fici, Aspergillus ruber, Penicillium palitans, Penicillium roqueforti and Trichoderma applanatum were first cloned in E. coli-Saccharomyces-Aspergillus shuttle vectors by PCR-based homologues recombination in E. coli or yeast and the constructs were then successfully expressed in Aspergillus nidulans LO8030. Expression of such clusters led to accumulation of pathway products, which were identified by isolation and structural elucidation. Subsequent gene deletion and feeding experiments as well as biochemical characterization of the recombinant key enzymes have been used for elucidation of the reaction steps in the 15 biosynthetic pathways, which revealed the presence of novel enzymes or reactions in their biosynthesis. These include the formation mechanism of peniphenones and penilactones in P. crustosum, the first fungal enzyme FnsA for the flavonoid biosynthesis in P. fici, the bifunctional PKS OesA from P. crustosum, the lactone-forming bridge enzyme-like protein AnuG from P. roqueforti and the P450 enzyme VdoD from P. palitans for meta-hydroxylation at a monosubstituted benzene ring.

Publications

 
 

Additional Information

Textvergrößerung und Kontrastanpassung